Dynamic Dashboard

The Global AMR R&D Hub’s Dynamic Dashboard continuously collects and presents information on more than 8 bn USD AMR R&D investments from across the One Health continuum – human, animal, plant and environment. It also presents information on antibacterial products in the clinical development pipeline and incentives for antibiotic R&D.

 

 

Animal health R&D in LMICs

23.11.2021: Antimicrobial resistance is a global public health threat that disproportionately affects low- and middle-income countries (LMICs). It presents risks to human health and also has severe implications for the health and welfare of animal populations, with major food security ...

Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation

17.11.2021: 20 national and international organisations from academia, healthcare, global health and the pharmaceutical industry - including the Global AMR R&D Hub - appeal to G7 governments to step up efforts to tackle the growing problem of antibiotic resistance. Read more...

Cloud-based visualization of data serves science in the global fight against resistant pathogens

08.10.2021: Where science meets digitalization: the Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub, works with huge amounts of research data from all around the world. In its mission to combat resistance to antimicrobial medication, the Hub needed a ...

Funded by: